Apyx Medical Corporation · GETTEX:BOV

Apyx Medical Corporation financial statements

Apyx Medical Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue52.8M48.1M52.3M44.5M48.5M27.7M28.2M16.6M10.2M8.82M
Cost of revenue19.8M18.7M18.6M15.4M14.9M10.2M9.14M5.78M3.28M3.70M
Gross profit33.0M29.4M33.8M29.1M33.6M17.5M19.1M10.8M6.96M5.12M
Research and development3.37M5.08M5.44M4.54M4.32M3.92M3.73M2.55M1.94M1.03M
Selling, general and administrative15.8M18.9M22.2M20.5M18.6M11.7M13.7M9.41M8.69M6.18M
Operating income-6.45M-18.8M-17.3M-23.6M-14.4M-20.1M-20.9M-14.3M-13.9M-11.4M
Depreciation and amortization655.0K599.0K692.0K890.0K903.0K887.0K754.0K669.0K696.0K734.0K
EBITDA-5.79M-18.2M-16.6M-22.7M-13.5M-19.2M-20.1M-13.6M-13.2M-10.7M
Interest expense5.59M5.91M2.48M15.0K10.0K46.0K8.00K104.0K136.0K158.0K
Income before tax-10.8M-23.3M-21.3M-22.9M-14.8M-19.4M-19.8M-14.7M-13.8M-11.5M
Income tax270.0K252.0K-2.43M367.0K380.0K-7.50M-130.0K-3.91M-156.0K64.0K
Net income-11.2M-23.5M-18.7M-23.2M-15.2M-11.9M-19.7M62.7M-5.06M-11.6M
Earnings per share, basic-0.27-0.66-0.54-0.67-0.44-0.35-0.581.89-0.16-0.14
Earnings per share, diluted-0.54-0.67-0.44-0.35-0.581.83-0.17-0.15

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents31.7M31.7M43.7M10.2M30.9M41.9M58.8M16.6M9.95M14.5M
Short-term investments39.7M061.7M0779.0K
Receivables16.8M15.5M14.0M10.6M13.0M8.40M7.99M5.08M4.86M4.73M
Inventory8.60M7.56M9.92M11.8M6.78M4.05M5.07M5.30M4.27M6.16M
Current assets58.5M56.4M70.4M43.0M60.7M66.1M76.7M89.8M22.5M26.5M
Property, plant and equipment2.37M1.99M1.92M6.76M6.58M6.54M6.62M5.79M6.03M6.45M
Goodwill185.0K185.0K185.0K
Total assets66.8M64.8M79.2M51.8M68.7M74.1M84.7M95.9M31.0M35.1M
Accounts payable3.06M2.62M2.71M2.67M2.63M1.51M2.44M1.42M1.58M1.61M
Current liabilities11.7M10.7M12.7M11.8M13.2M9.15M12.3M8.61M5.97M5.27M
Long-term debt34.8M33.9M33.2M002.46M2.69M
Total debt37.5M37.5M33.2M0305.0K676.0K1.13M02.69M2.93M
Total liabilities52.0M50.5M52.3M14.0M14.7M10.3M13.5M8.75M8.96M8.89M
Shareholders' equity14.5M14.2M26.7M37.6M53.7M63.7M71.3M87.2M22.0M26.2M
Shares outstanding41.8M37.8M34.6M34.6M34.4M34.3M34.2M33.7M32.9M30.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.00M-18.0M-5.25M-20.3M-10.4M-16.1M-18.5M-20.9M-3.70M-2.84M
Capital spending-1.11M-722.0K-533.0K-1.01M-723.0K-581.0K-1.30M-363.0K-624.0K-286.0K
Free cash flow-9.12M-18.8M-5.78M-21.3M-11.2M-16.6M-19.8M-21.2M-4.33M-3.12M
Cash from investing-1.11M-722.0K6.73M-1.01M-723.0K-581.0K60.5M29.3M-624.0K-286.0K
Cash from financing9.58M6.75M32.2M217.0K24.0K-73.0K147.0K-2.49M-239.0K5.71M
Share buybacks195.0K148.0K207.0K202.0K5.83M
Change in cash-1.00K-11.9M33.5M-20.7M-11.0M-16.9M42.2M5.93M-4.57M2.65M